REGENERON PHARMACEUTICALS
REGN·75886F107·US·Common Stock·Healthcare - Biotechnology-13D/G
REGN (REGENERON PHARMACEUTICALS) is held by 328 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($6.9B), VANGUARD CAPITAL MANAGEMENT LLC ($5.1B), STATE STREET CORP ($3.6B). Net institutional sentiment: Mixed. In Q1 2026, 8 members of Congress and 188 funds bought REGN.
328
Holders
(28 Elite)
$62.8B
Total Value
56% (337)
Consensus
188 buying - 149 selling
13F: Insider & Congress:
Who's Trading
InsiderRFRYAN ARTHUR FSell $130KJul 2, 2026
InsiderRFRYAN ARTHUR FSell $4KMay 1, 2026
InsiderRFRYAN ARTHUR FSell $11KMay 1, 2026
InsiderRFRYAN ARTHUR FSell $17KMay 1, 2026
Showing 1-20 of 341
1 / 18
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer